3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Sarcoma
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
36
Magnetic Resonance Spectroscopy
31
Cyclophosphamide
26
Doxorubicin
23
Biopsy
22
pembrolizumab
21
Temozolomide
21
X-Rays
17
Radiotherapy
17
Radiation
16
Nivolumab
13
atezolizumab
12
Vincristine
12
Phantoms, Imaging
12
Irinotecan
12
Ifosfamide
12
Gemcitabine
12
fludarabine
11
cabozantinib
10
liposomal doxorubicin
8
Surgical Procedures, Operative
8
Ipilimumab
8
Etoposide
8
Bevacizumab
8
Paclitaxel
7
Immunoglobulin G
7
Carboplatin
7
palbociclib
6
olaparib
6
fludarabine phosphate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Angptl4 protein, mouse
×
Sarcoma
×
90 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled